Prognostic value of the mutation types and dynamics of FLT3‐ITD in acute myeloid leukemia
- 12 July 2023
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 111 (4) , 562-572
Abstract
Objective: The prognostic value of the mutation types and dynamics of FLT3‐ITD in acute myeloid leukemia (AML) and other known factors were studied.Methods: Initial and follow‐up samples from 45 AML patients with FLT3‐ITD mutations were analyzed by fragment length analysis, Sanger sequencing, and next‐generation sequencing.Results: Some patients (13%) had multiple FLT3‐ITD mutations, and many of them had acute promyelocytic leukemia (APL). FLT3‐ITD mutations were classified according to mutation types, including duplication‐only FLT3‐ITD (52%) and FLT3‐ITD with duplications and insertions (dup + ins) (48%). The dup + ins FLT3‐ITD variant was independently associated with poor prognosis among non‐APL patients (odds ratio, 2.92) in addition to FLT3‐ITD with ≥50% variant allele frequency (VAF). The VAFs of FLT3‐ITD were low (median 2.2%) when detected during morphologic complete remission (CR) after conventional chemotherapy; however, in two patients treated with gilteritinib after relapse, the VAFs of FLT3‐ITD were much higher (>95% and 8.1%) in the morphologic CR state.Conclusions: The type of FLT3‐ITD mutation is important in prognosis, and the dup + ins type of FLT3‐ITD can be an indicator of poor prognosis. In addition, the FLT3‐ITD mutation status may unexpectedly not match the morphologic examination results after gilteritinib treatment.Keywords
Funding Information
- Ministry of Education (NRF‐2020R1I1A3A04037773)
This publication has 36 references indexed in Scilit:
- NUP98‐NSD1 fusion in association with FLT3‐ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCRGenes, Chromosomes and Cancer, 2013
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next-Generation Sequencing DataThe Journal of Molecular Diagnostics, 2013
- Next‐generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3‐ITD or NPM1 mutationsGenes, Chromosomes and Cancer, 2012
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcomeBlood, 2009
- Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptorBlood, 2009
- A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogeneticsBritish Journal of Haematology, 2008
- Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemiaLeukemia, 2005
- Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemiaLeukemia, 2004